Skip to content

Merits of Continuous Paravertebral Block in the Management of Renal/Adrenal Surgery by Laparotomy

Consideration of the Merits of Continuous Paravertebral Block in the Management of Renal and/or Adrenal Surgery by Laparotomy in Adults

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01023854
Acronym
BPV
Enrollment
41
Registered
2009-12-02
Start date
2009-10-31
Completion date
2013-09-30
Last updated
2014-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indication for Renal and/or Adrenal Surgery

Keywords

Paravertebral block, loco regional anesthesia, renal surgery, PCA morphine

Brief summary

The paravertebral block is an alternative in the analgesia epidural the major interest of which lives in the catheterisation of the paravertébral space allowing to assure/insure an one-sided continuous analgesia. The main objective of the study is to bring to light the superiority of the continuous paravertébral block, as a supplement to analgesia, in the care of the renal and\\or adrenal surgery by laparotomy at the adult in terms of consumption of morphine, with regard to the classic analgesia classic. The main assessment criterion is the consumption of morphine within first 24 postoperative hours at the patients benefiting from a paravertébral continuous block besides the classic systematic analgesia.

Interventions

PROCEDUREContinuous Paravertebral block

The paravertébral block is a peripheral block which gets an one-sided continuous analgesia by infiltration of the spinal nerves which appear from the intervertebral foramen. Its realization consists of a draining in 2-3 cm of the thorny apophyses ( T6-T8). During the perception of the osseous contact (cross-functional process of the vertebra), the needle is redirected in cephalic direction until a loss of resistance corresponding to the passage of the upper costo-cross-functional ligament that is in the entrance to the paravertébral space. A catheter is then inserted into the paravertébral space.

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Patient scheduled for renal and/or adrenal surgery * American Society of Anesthesiologists score ASA I, II, III * Written informed consent given by the patient

Exclusion criteria

* Contraindication in the loco-regional anesthesia in the products of local anesthetic * Surgery as a matter of urgency * Pregnancy * Congestive Cardiac insufficiency * Severe hepatic Incapacity * Disturbs of the coagulation * Age \< 18 years * ASA IV * Patient already participating in a study or deadline 3-month-old subordinate since the end of a previous study * Under guardianship Patient * Psychiatric pathology or limitation of the intellectual abilities making difficult the understanding of the subjective questions.

Design outcomes

Primary

MeasureTime frame
morphine consumption during the first 24 hours24 hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026